Leonteq Securities’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
Other funds holding NKTR
Leonteq Securities's NKTR Position: Q3 2026 in Review
Leonteq Securities reduced its Nektar Therapeutics (NKTR) stake by 9.1% in Q3 2026, selling an estimated $28.1K and leaving 4,000 shares worth $242K. The position accounts for 0.01% of the portfolio, ranked #463.
Leonteq Securities first reported a position in NKTR in Q4 2025 and has held it in 4 quarters since. The position peaked at $338K in Q4 2025. 240 funds tracked by Wall St. Rank hold NKTR as of Q3 2026.
- Leonteq Securities held 4,000 shares of Nektar Therapeutics worth $242K as of Q3 2026.
- Leonteq Securities sold 400 Nektar Therapeutics shares in Q3 2026, an estimated $28.1K.
- Nektar Therapeutics made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #463 holding.
- Leonteq Securities first reported a position in Nektar Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Leonteq Securities's Nektar Therapeutics position peaked at $338K in Q4 2025.
- 240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.